Add Company
Join Now

NeRRe Therapeutics Revenue and Competitors

License our Company Data API

Stevenage,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NeRRe Therapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • NeRRe Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • NeRRe Therapeutics has 11 Employees.(i)
  • NeRRe Therapeutics grew their employee count by 0% last year.

NeRRe Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Clinical OperationsReveal Email/Phone
3
SVP, CMC - NeRRe TherapeuticsReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
Co-Founder & Chief Scientific OfficerReveal Email/Phone
6
Chief Financial OfficerReveal Email/Phone
7
Office Manager/Executive AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is NeRRe Therapeutics?

NeRRe Therapeutics is a clinical stage company progressing a unique portfolio of three neurokinin-1 antagonists (NK-1RAs) for the treatment of common, chronic and debilitating conditions, caused by neuronal hypersensitivity related to NK-1 receptor system dysfunction. It's lead compound orvepitant is in a multinational Phase 2b trial in patients suffering from chronic refractory cough, a neuronal hypersensitivity condition for which there are no approved treatments.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M150%N/A
#2
$1.2M1515%N/A
#3
$2.3M23N/AN/A
#4
$4.3M23-8%N/A
#5
$5.3M280%N/A